Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 077337
Company: TEVA
Company: TEVA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 500MG;EQ 2MG BASE | TABLET;ORAL | Discontinued | None | No | No |
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 500MG;EQ 4MG BASE | TABLET;ORAL | Discontinued | None | No | No |
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 1GM;EQ 2MG BASE | TABLET;ORAL | Discontinued | None | No | No |
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 1GM;EQ 4MG BASE | TABLET;ORAL | Discontinued | None | No | No |
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 500MG;EQ 1MG BASE | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
05/19/2017 | ORIG-2 | Approval |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/077337Orig1s000lbl.pdf | |||
05/07/2014 | ORIG-1 | Approval |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/077337Orig1s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/077337Orig1s000ltr.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/05/2017 | SUPPL-1 | Labeling-Medication Guide, Labeling-Package Insert |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/077337Orig1s000ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
05/19/2017 | ORIG-2 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/077337Orig1s000lbl.pdf | |
05/07/2014 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/077337Orig1s000lbl.pdf |